← All candidates
153 insider filings on record.
153 filings on record.
CTKBCytek Biosciences, Inc.
NasdaqGS · Healthcare · $640.82M
$4.93
+0.82% today
153 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$640.82M
Float
102.9M
79% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
70.4
Price / sales
3.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Financial Officer
McCombe William D.
Bought $97.3K on Jun 2 — 35,000 sh @ $2.78, held direct, 63% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
148 more transactions on Pro →The file stays open
153 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice